Home/Filings/4/0001104659-19-034353
4//SEC Filing

Sawhney Amarpreet 4

Accession 0001104659-19-034353

CIK 0001393434other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 6:09 PM ET

Size

12.4 KB

Accession

0001104659-19-034353

Insider Transaction Report

Form 4
Period: 2019-06-04
Sawhney Amarpreet
DirectorPresident and CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2019-06-04$2.92/sh+12,928$37,750898,711 total
  • Purchase

    Common Stock

    2019-06-05$2.91/sh+32,852$95,599931,563 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    846,377
  • Common Stock

    (indirect: See Footnote)
    471,784
  • Common Stock

    (indirect: See Footnote)
    71,969
  • Common Stock

    (indirect: See Footnote)
    379,419
  • Common Stock

    (indirect: See Footnote)
    189,393
Footnotes (7)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.89 to $2.95, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.87 to $2.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F3]The securities are directly held by Incept, LLC. The Reporting Person is a general partner of Incept, LLC. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
  • [F4]The securities are directly held by the Sangam Trust. The Reporting Person and his immediate family members are beneficiaries of the Sangam Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
  • [F5]The securities are directly held by the SAFIGS Trust. The Reporting Person's immediate family members are beneficiaries of the SAFIGS Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
  • [F6]The securities are directly held by the Sawhney Family Dynasty Trust. The Reporting Person's immediate family members are beneficiaries of the Sawhney Family Dynasty Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
  • [F7]The securities are directly held by the Amarpreet S. Sawhney 2014 GRAT. The Reporting Person and his immediate family members are beneficiaries of the Amar S. Sawhney 2014 GRAT. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.

Documents

1 file

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0001614417

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:09 PM ET
Size
12.4 KB